secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alpha Teknova, Inc. (TKNO)
CIK:        0001850902
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0000950170-25-067005
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teknova Q1 revenue up 5% to $9.8M, net loss narrows to $4.6M, guidance reaffirmed
--------------------------------------------------------------------------------

- Q1 total revenue $9.8M (+5% YoY); Lab Essentials $8.1M (+12%), Clinical Solutions $1.2M (-32%).
- Net loss narrowed to $4.6M ($0.09/share) from $8.1M ($0.20/share) in Q1 2024.
- Adjusted EBITDA loss improved to $2.5M from $3.8M; free cash outflow decreased to $4.3M from $6.7M.
- Exclusive collaboration with Pluristyx to manufacture/distribute PluriFreeze cryopreservation system in US/Canada.
- Reaffirms FY2025 revenue guidance of $39-42M and free cash outflow under $12M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850902/000095017025067005/0000950170-25-067005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850902/000095017025067005/tkno-20250508.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-067005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer